
Talazoparib Capsule 1 mg (Talazoparib Tosylate)
Prescription medication
Pfizer Korea Co., Ltd.
Talazoparib tosylate is an anti-cancer agent used in the treatment of certain cancers.
MFDS ingredient code M279255
Talazoparib tosylate belongs to the class of PARP inhibitors. It is primarily used for the treatment of specific cancers such as breast cancer and ovarian cancer. This agent induces cancer cell death by disrupting the ability to repair DNA damage in cancer cells.
Talazoparib tosylate inhibits the PARP enzyme responsible for DNA repair in cancer cells. As a result, cancer cells are unable to repair their own DNA damage and ultimately die. It has a greater impact on cancer cells than on normal cells, leading to therapeutic efficacy.
Approved uses differ by product. Check each product's information for its actual use.
Talazoparib tosylate exhibits high efficacy and selectivity compared to other PARP inhibitors. It is particularly effective in cancer patients with BRCA gene mutations. This distinguishes it from other anti-cancer agents.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
3 total

Prescription medication
Pfizer Korea Co., Ltd.

Hard capsule · Prescription medication
Pfizer Pharmaceuticals Korea Co., Ltd.

Hard capsule · Prescription medication
Pfizer Pharmaceuticals Korea Co., Ltd.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.